(Q46648460)

English

Retrospective analysis of rosiglitazone and macular oedema in patients with type 2 diabetes mellitus

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

Retrospective analysis of rosiglitazone and macular oedema in patients with type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

type 2 diabetes

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

author name string

Patrizio Tatti

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

Franco Arrigoni

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

Adriano Longobardi

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

Flavia Costanza

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

Patrizia Di Blasi

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

Domenico Merante

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

28

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

327-332

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

Rosiglitazone (Avandia) and macular edema

1 reference

https://api.crossref.org/works/10.2165%2F00044011-200828050-00006

21 January 2018

Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18407718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined thiazolidinedione-insulin therapy: should we be concerned about safety?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18407718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differentiating members of the thiazolidinedione class: a focus on efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18407718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones

1 reference

https://pubmed.ncbi.nlm.nih.gov/18407718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vision loss due to macular edema induced by rosiglitazone treatment of diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18407718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/18407718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic retinopathyA clinical update

1 reference

https://pubmed.ncbi.nlm.nih.gov/18407718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/18407718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Threshold Amsler grid testing in diabetic retinopathy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18407718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Ishihara test and defects of colour vision

1 reference

https://pubmed.ncbi.nlm.nih.gov/18407718

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200828050-00006

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18407718

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46648460&oldid=2124261854"